On Monday December 11 (next week) phase I of the availability of generic Viagra will kick in (here in the US), and those of us who need / want this product to help cope with ED should see a roughly 50 percent drop in the price … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: ED, generic, sildenafil, Viagra | 3 Comments »
Prostate cancer patients in the UK may want to know (if they don’t already) that the erectile dysfunction drug sildenafil (Viagra) will become available as an “over the counter” or OTC drug called Viagra Connect early next year. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: counter, OTC, over, sildenafil, UK, Viagra | 1 Comment »
In what may be an important piece of information for many men with prostate cancer, the U.S. Food and Drug Administration yesterday approved the first generic form of the erectile dysfunction drug sildenafil or Viagra. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: generic, sildenafil, Viagra | 3 Comments »
Daily treatment with sildenafil citrate (Viagra) seems to have been able to help maintain erectile function for up to 2 years among men receiving such adjuvant treatment during and after radiotherapy for localized prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: delay, dysfunction, erectile, Prevention, radiotherapy, sildenafil, Viagra | 1 Comment »
According to a story on the FiercePharma web site, the patent for sildenafil (Viagra) will expire today in Europe. This ought to lead to a significant drop in the price for a very popular drug as generic equivalents rapidly come available. Here in the USA, however, Pfizer has managed to extend the patent for Viagra to 2020 (through litigation).
Filed under: Living with Prostate Cancer | Tagged: generic, patent, sildenafil, Viagra | 2 Comments »
Data from a newly-published (but very small) randomized, double-blind, placebo-controlled clinical trial show no significant, clinical impact of sildenafil (Viagra®) taken once daily as a treatment to optimize retention of erectile function at up to 2 years after radiation therapy for localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: erectile, function, radiation, sildenafil, Viagra | Leave a comment »
According to a thoroughly confusing media release from the Virginia Commonwealth University last week, “the impotence drug Viagra, in combination with doxorubicin, a powerful anti-cancer drug, enhances its anti-tumor efficacy in prostate cancer while alleviating the damage to the heart at the same time.” … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management | Tagged: doxorubicin, sildenafil, Viagra | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 